Central African Republic vs India: HIV-positive TB patients on ART (antiretroviral therapy)
Central African Republic
98.0%
in 2024
India
98.0%
in 2024
Central African Republic rank
64th
India rank
64th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Central African Republic
- India
How they compare
Central African Republic currently reports 98.0% against 98.0% in India, a difference of 0.0%.
The two have swapped places 6 times across 14 shared years of data; in 2009 it was India ahead.
Central African Republic ranks 64th and India ranks 64th of 144 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.0% | 50.0% | 15.0% | India |
| 2010s | 66.3% | 78.6% | 12.3% | India |
| 2020s | 96.8% | 96.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Central African Republic or India?
- Central African Republic, at 98.0% against 98.0% in India as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Central African Republic and India?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and India?
- 14 years are reported by both, from 2009 to 2024.
- How do Central African Republic and India rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Central African Republic ranks 64th and India ranks 64th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.